Dr. Dimitar V. Zlatev, MD

Dr. Zlatev practices at Surgery Nevada in Reno, Nevada.

Dr. Zlatev's NPI, 1841589132, was assigned on April 7, 2011. Dr. Zlatev graduated from Feinberg School of Medicine in 2011. Dr. Zlatev holds Nevada license 24207.

Dr. Zlatev's primary practice is Surgery Nevada, at 5560 Kietzke Lane, Reno, NV 89511.

Dr. Zlatev's primary practice is Surgery Nevada in Reno, Nevada. Dr. Zlatev is also affiliated with Renown Regional Medical Center. The medical group on file is Urology Nevada. Dmand AI also links Dr. Zlatev to 4 more hospitals, 6 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zlatev practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Zlatev's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Zlatev is board certified in urology by the American Board of Urology. Dmand AI has Dr. Zlatev's licenses on file in 6 states: Nevada, California, Massachusetts, New Hampshire, Maine and Rhode Island.

Dmand AI lists bladder disease, bladder removal, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, prostate cancer and prostate surgery among the conditions Dr. Zlatev treats.

CMS data shows 1,563 Medicare services from Dr. Zlatev across 22 procedure codes in 2024, for 487 Medicare patients. Medicare paid $135,132 for them.

CMS counts 487 Medicare patients who saw Dr. Zlatev in 2024. The largest group is 65 to 74, with 249 patients. 73% of them have high cholesterol, and 71% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zlatev's median patient age at 69, with 16% women.

In 2024, Dr. Zlatev wrote 443 Medicare Part D claims for 171 patients. 99% of them were for generic drugs. CMS names the drug for 348 of them, across 7 drugs with 11 or more claims each, at $3,829 in total drug cost. In 2023, CMS named 71 claims across 2 drugs.

Dr. Zlatev accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zlatev as offering telehealth. CMS counts 53 procedures of prostate resection by Dr. Zlatev, more than 97% of the clinicians it reports for that procedure.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 25 papers to Dr. Zlatev, published from 2015 to 2024. 2019 was the busiest year, with 6. The most frequent topics are Microscopy, Confocal, Prostatic Neoplasms and Spinal Cord Injuries. Dr. Zlatev has published most often in Urol Clin North Am. Dr. Zlatev's most frequent co-authors are Joseph Chihping Liao, MD, Christopher S. Elliott, MD and Kazuko Liao Shem, MD.

CMS Open Payments shows 29 general payments to Dr. Zlatev from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Janssen Pharmaceuticals, Inc paid the most, $534.

Dr. Zlatev graduated from Feinberg School of Medicine in 2011.

Dr. Zlatev is in network with 20 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.